Advanced Oncotherapy (LON:AVO) Stock Price Passes Above Fifty Day Moving Average – Time to Sell?

by · The Cerbat Gem

Shares of Advanced Oncotherapy plc (LON:AVO – Get Free Report) crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of GBX 1.75 ($0.02) and traded as high as GBX 1.75 ($0.02). Advanced Oncotherapy shares last traded at GBX 1.75 ($0.02), with a volume of 200,000 shares.

Advanced Oncotherapy Price Performance

The firm’s 50-day moving average price is GBX 1.75 and its two-hundred day moving average price is GBX 1.75. The company has a debt-to-equity ratio of 98.71, a quick ratio of 0.13 and a current ratio of 1.26. The firm has a market cap of £9.50 million, a PE ratio of -25.00 and a beta of 0.06.

Advanced Oncotherapy Company Profile

(Get Free Report)

Advanced Oncotherapy plc, together with its subsidiaries, engages in designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties.

Featured Articles